Clinical Trial Update: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) [Phase 1]

View source ↗

Summary

An ongoing Phase 1 clinical trial sponsored by NIAID is evaluating a microbiome-based therapy for atopic dermatitis (TIME-2) and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• TIME-2 Microbiome Therapy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis | Phase 1 | Status: RECRUITING